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Background: Humeral shaft fractures account for 1 to 3% of all fractures in adults and for 20% of all humeral fractures.
Non-operative treatment is still the standard treatment of isolated humeral shaft fractures, although this method can
present unsatisfactory results. Surgical treatment is reserved for specific conditions. Modern concepts of internal fixation
of long bone shaft fractures advocate relative stabilisation techniques with no harm to fracture zone. Recently
described, minimally invasive bridge plate osteosynthesis has been shown to be a secure technique with good results
for treating humeral shaft fractures. There is no good quality evidence advocating which method is more effective. This
randomised controlled trial will be performed to investigate the effectiveness of surgical treatment of humeral shaft
fractures with bridge plating in comparison with conservative treatment with functional brace.
Methods/Design: This randomised clinical trial aims to include 110 patients with humeral shaft fractures who will be
allocated after randomisation to one of the two groups: bridge plate or functional brace. Surgical treatment will be
performed according to technique described by Livani and Belangero using a narrow DCP plate. Non-operative
management will consist of a functional brace for 6 weeks or until fracture consolidation. All patients will be included
in the same rehabilitation program and will be followed up for 1 year after intervention. The primary outcome will be
the DASH score after 6 months of intervention. As secondary outcomes, we will assess SF-36 questionnaire, treatment
complications, Constant score, pain (Visual Analogue Scale) and radiographs.
Discussion: According to current evidence shown in a recent systematic review, this study is one of the first
randomised controlled trials designed to compare two methods to treat humeral shaft fractures (functional brace and
bridge plate surgery).
Trial registration: Current Controlled Trials: ISRCTN24835397
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Humeral shaft fractures account for 1 to 3% of all frac-
tures in adults [1,2] and for 20% of all humeral fractures
[3]. These fractures have an annual incidence from 13
to 14.5 per 100,000 people [4,5]. Non-operative treat-
ment is still the standard treatment for isolated humeral
shaft fractures [6,7], although this method can present
unsatisfactory results, such as, nonunion and shoulder
impairment [8,9]. Fourteen percent of patients treated
with this method have restricted range of motion and
12.6% have consolidation, with more than 10° of dis-
placement [10].
Surgical treatment is recommended for patients with
neurovascular injuries, medullar or brachial plexus in-
juries, and open fractures, for patients with multiple
injuries, and for floating elbow and unsatisfactory
reductions [11-13]. Humeral shaft fractures can also
be treated surgically for the following indications:
Arbeitsgemeinschaft für Osteosynthesefragen (AO)-
Orthopaedic Trauma Association (OTA) type A frac-
tures, proximal third oblique fractures and distal
third shaft fractures [14-16]. Surgical options for
treatment of humeral shaft fractures include open re-
duction and internal fixation with a compression
plate, intramedullary nail osteosysthesis and minim-
ally invasive bridge plate fixation. Open reduction and
rigid internal fixation with absolute stability using dy-
namic compression plates [17-19] is today’s standard
and is the more common surgical option for treatment
of these fractures.
Modern concepts of internal fixation of shaft frac-
tures of the long bones advocate relative stabilisation
techniques with no harm to the fracture zone. These
have largely been used for fractures of the leg and thigh
for which they have become the gold standard treat-
ment. In humeral shaft fractures, these concepts are
also being applied with the use of the intramedullary
nail [20-22]. In a systematic review, when compared to
compression plate osteosynthesis, the use of the
intramedullary nail presented a higher risk of shoulder
impingement, shoulder pain, and restriction of move-
ments [23]. Recently described by Livani and Belangero
[24], minimally invasive bridge plate osteosynthesis
with anterior access has been shown to be a secure
technique with good results for the majority of hu-
meral shaft fractures [25-27].
Good quality evidence, including trials comparing sur-
gical and nonsurgical interventions for treating these
fractures, is lacking [28]. This study will, therefore, be
performed to investigate the effectiveness of surgical
treatment of humeral shaft fractures with bridge plating
in comparison with conservative treatment with a func-
tional brace, considering patients’ superior limb func-
tion, their quality of life and treatment complications.Methods
This randomised controlled trial will follow the Consoli-
dated Standards of Reporting Trials (CONSORT) Statement
[29]; it will be performed in the Hand and Upper Limb Sur-
gery Institute of the Orthopaedics and Traumatology De-
partment of Universidade Federal de Sao Paulo and was
approved by the ethical committee (CEP UNIFESP 1595/
09). The project is registered in the Current Controlled Tri-
als database (ISRCTN 24835397 http://www.controlled-tri-
als.com/ISRCTN24835397), and was cited by a Cochrane
Systematic Review [28]. This study has its funding approved
under the process number 2011/21611-2 by a government-
based noncommercial agency: Fundação de Amparo à
Pesquisa do Estado de São Paulo (FAPESP).
Inclusion criteria
All patients eighteen years of age or older, with completely
deviated humeral shaft fractures (between 4 cm distal to
the surgical neck of the humerus and 4 cm proximal to the
superior border of the olecranon fossa), who agree to par-
ticipate and give written informed consent, will be included
in the study.
Exclusion criteria
Patients with pathological or open fracture, previous dis-
ease in the limb that could influence the results, an imma-
ture skeleton, those whose fracture occurred more than
21 days previously or those with neurovascular-associated
injury will be excluded. If patients do not wish to partici-
pate or are unable to understand or sign the informed
consent form (due to conditions such as cognitive impair-
ment, or mental illness), if poor compliance is expected,
or if there any conditions that contraindicate any of the
methods for randomized, will also be considered exclusion
criteria. Patients who have high risk of anaesthesiology-
associated problems will also be excluded.
Sample size
The sample size was calculated for a significance level of
0.05, statistical power of 90% and SD of 15% in Disability
of the Arm, Shoulder and Hand (DASH) scores and an ab-
solute difference between the groups of 10 points in the
DASH scores. It was calculated that 50 patients were
needed in each group [30,31]. Allowing for a 10% loss to
follow up at 24 weeks, we aim to recruit a total of 110
patients.
Randomisation and allocation
The randomisation sequence will be generated by com-
puter software (http://www.randomizer.org), creating a
list from 1 to 110, each number being related to one of
the two proposed methods of treatment. We will per-
form simple (unrestricted) randomisation, making the
intervention assignment unpredictable, including the
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the 110 opaque sealed envelopes numbered from 1 to
110, will be a piece of paper containing the words ‘func-
tional brace’ or ‘bridge plate.
Participant allocation will be performed after explaining
the protocol and describing both of the procedures to be
randomised, and after participants have agreed to take
part and signed the informed consent form (Additional
file 1 and Additional file 2). They will also be clinically
evaluated to determine whether they are suitable candi-
dates for surgery. After this, an independent person will
open the envelope before proceeding to the intervention
(Figure 1).Figure 1 Flow of participants. Diagram shows the planned flow of particIntervention methods
Nonsurgical treatment (functional brace)
Patients randomised to nonsurgical treatment will
undergo closed reduction and initial immobilisation
with a coaptation U-splint [32] (Figure 2) from the axilla
to the elbow, ending in the deltoid. After 14 days, the im-
mobilisation will be replaced by a functional brace [6]
(Figure 3) allowing the patients to move their shoulder
and elbow freely to exercises and rehabilitation. This brace
will be kept until fracture consolidation, determined on
radiography by two previously-assigned assessors. Any
disagreements will be resolved by discussion with a third
assessor.ipants through each stage of the study.
Figure 2 Initial immobilisation with the splint.
Figure 3 Functional brace.
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Patients randomised to surgical treatment will undergo
preoperative evaluation of age, clinical condition (acute in-
fection) and co-morbidities. The intervention will take
place in the surgical centre of the institution, where four
previously-specified surgeons, who are experienced with
the surgical technique described by Livani and Belangero
[24], will perform the surgical procedures. After the anaes-
thetic procedure, the patient will be kept in the horizontal
dorsal decubitus position and two incisions will be made.
The 3 to 5 cm proximal incision will access the proximal
fragment between the biceps brachii muscle medially and
the deltoid muscle laterally. The 3 to 5 cm distal incision
will expose the anterior humeral cortex of the distal frag-
ment, after dissection of the lateral cutaneous nerve of the
forearm, and after the brachialis muscle is split longitudin-
ally (Figure 4). In distal-third fractures, the lateral columnof the distal humerus will be accessed with subperiosteal
dissection of the lateral supracondylar crest and reflection
of the brachioradialis and extensor carpi radialis longus
muscles and the radial nerve. After indirect reduction
under fluoroscopy, a narrow 4.5-mm dynamic compression
plate (DCP) will be used and will be introduced in a prox-
imal to distal direction (Figure 5). In fractures of the distal
third of the humeral shaft, the plate will be introduced in a
distal to proximal direction. Two to three screws will be
inserted in each bone fragment. After osteosynthesis, final
Figure 4 Surgical incisions for minimally invasive bridge
plate osteosynthesis.
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and bandaged The patient will be kept immobilised with a
sling until ambulatory evaluation.
Treatment after the intervention
Patients from both of the randomised groups will be in-
cluded in the same rehabilitation programme. Free-elbow
passive and active motion and pendulum exercises for the
shoulder will be allowed as soon as the patient can toleratethem. Internal and external shoulder rotations will be in-
troduced 6 weeks after the intervention.
Outcome assessment
All study participants will be evaluated at 2 and 4 weeks;
2, 6 and 12 months after the intervention. Radiographic
evaluations, pain measurements using the visual analogue
scale (VAS) [33], and application of the DASH [30,34]
(Additional file 3 and Additional file 4), Short Form (SF)-
36 and Constant shoulder score questionnaires will be
performed by professional orthopaedists and physiothera-
pists who will not be directly associated with the study.
Assessors will be blinded to the treatment assignment.
Prior to outcome functional assessments, patients will be
instructed not to reveal their treatment and will have their
fractured arm covered with an opaque gown, identical in
both groups [35].
Primary outcome
Our primary outcome will be the DASH [30,34] scores
6 months after the procedure (either surgical or
nonsurgical) for treatment of humeral shaft fractures.
The final score will be calculated using the specified
formula:
DASH score ¼ Raw score−30ð Þ=1:2:
The two optional modules of the DASH questionnaire
will not be applied in this study.
Secondary outcomes
Secondary outcome measures include: (i) the SF-36 ques-
tionnaire [36,37], (ii) procedure complications, (iii) pain,
measured by the VAS [33], (iv) Constant questionnaire
functional score [38]; (v) radiographic characteristics in
terms of (a) consolidation of the fracture and (b) displace-
ment and angulation of the fracture fragments.
The SF-36 is a questionnaire containing 36 items. This
survey assesses eight health concepts: physical function-
ing, bodily pain, limitations due to health problems, limi-
tations due to personal or emotional problems, emotional
well-being, social functioning, energy/fatigue and general
health perceptions. The VAS consists of a 10-cm line an-
chored by two extremes: ‘no pain’ and ‘pain as bad it could
be’. Patients are asked to make a mark on the line, which
represents the intensity level of their perceived pain, and
the scale is scored by measuring the distance from ‘no
pain’ to the patient’s mark.
Consolidation will be considered as a dichotomous
variable: fracture healing or no healing. Displacement
and angulation of bone fragments will be measured on
radiographs.
Figure 5 Postoperative radiography.
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Patients, who for any reason demonstrate that their treat-
ment may require additional interventions, will be followed
up, and their results will be included in the group into
which these patients had initially been randomised,
according to the intention-to-treat principle. The Pearson
chi-squared test will be used to analyse the results from
the two groups in relation to the categorical variables, and
Student’s t-test will be used to compare the groups in rela-
tion to the numerical variables. Student’s t-test (paramet-
ric) will be used to compare the clinical evolution of each
group 2, 4, 8, 24 and 48 weeks after the intervention. For
the primary outcome, a significance level of 5% (alpha =
0.05) will be used for all statistical tests, such that tests
presenting a P-value less than 0.05 will be considered sta-
tistically significant. For the secondary outcomes we will
consider an alpha value of 0.02.Safety
Rates of complications are part of secondary outcome ana-
lysis and will be closely monitored. Expected complications
in both intervention groups include skin abrasion, skin
pressure ulcers, forearm and hand swelling, sensomotor
deficit, wound healing problems, hardware displacement
and failure, superficial and deep infection, malunion, non-
union, and shoulder and elbow impairment. Complications
will be categorized as minor or major according to their se-
verity. Causes of complications will be studied and they will
be treated as soon as detected. Complications that may
lead to surgical intervention, surgical revision, or clinically
important morbidity are classified as severe adverse events.
This protocol does not include a data safety monitoring
committee.Discussion
According to current evidence from a systematic review
[28], this study is one of the first randomised controlled
trials designed to compare surgical to nonsurgical man-
agement of humeral shaft fractures, to evaluate outcomes
of quality of life, safety and effectiveness.
Despite the risk of a surgical intervention, the minim-
ally invasive plate osteosynthesis technique seems to be
reproducible and applicable in almost all types of hu-
meral shaft fractures. It had the advantage of minimal
soft tissue dissection and lower rates of iatrogenic nerve
injury when compared to the conventional plate tech-
nique. Intramedullary nail osteosynthesis has resulted in
higher rates of reoperations and shoulder impairment
compared to the compression plate technique [23,25,27].
Functional bracing is a traditional method of treatment
but can have some complications, such as, nonunion in
proximal-third fractures, residual angulation of more
than 10˚ and skin abrasion [16,39].
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shaft cannot be surgically treated with this minimally in-
vasive technique, which is a limitation of this trial. An-
other limitation is the fact that this study will take place
in only one centre. This not only impacts recruitment,
but also may limit the generalisability of the results to
other settings. However, the use of broad inclusion cri-
teria is the strength of the trial.
This study aims to provide conclusive, good quality evi-
dence for orthopaedic practice and will contribute to the
evidence base of methods used to treat humeral shaft
fractures.
Trial status
This trial started recruiting patients on 6 May 2012.
Additional files
Additional file 1: Consent for participation in a research
(Portuguese).
Additional file 2: Consent for participation in a research (English).
Additional file 3: DASH questionnaire in Portuguese.
Additional file 4: DASH questionnaire in English.
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